Pharmacokinetics of Oral Nalbuphine in Hemodialysis Patients with Uremic Pruritus

Trial Profile

Pharmacokinetics of Oral Nalbuphine in Hemodialysis Patients with Uremic Pruritus

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2014

At a glance

  • Drugs Nalbuphine (Primary)
  • Indications Pruritus
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Trevi Therapeutics
  • Most Recent Events

    • 09 May 2014 Results presented at the at the 2014 Annual meeting of the society for Investigative Dermatology, according to Trevi Therapeutics media release.
    • 07 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top